TWiV 730: COVID-19 clinical update #53 with Dr. Daniel Griffin

In COVID-19 clinical update #53, Daniel Griffin reviews underreporting of infections and long term disease in children, a blood test for T cells, results of phase 3 trials for monoclonal antibodies, preliminary findings on an oral antiviral, clinical trial of ivermectin, and recommendations for upcoming gatherings. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode SARS-CoV-2 seroprevalence in EUA for T cell test (FDA) Lilly mAb phase 3 results (Lilly) VIR-7831 mAb phase 3 results (Globenewswire) Molnupiravir phase 2a results (Merck) Ivermectin not supported for mild COVID-19 (JAMA) Recommendations for fully vaccinated people (CDC) Letters read on TWiV 730 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]